Advertisement
Home Tags Cancer: Rectal

Tag: Cancer: Rectal

Researchers say they've pinpointed the best length of time to wait to perform surgery for rectal cancer after chemotherapy and radiation treatment have been completed. The findings were published online Jan. 20 in the Journal of the American College of Surgeons.

Rectal Cancer Surgery Best at 56 Days Post Chemo/Radiation

0
Patients who had procedure eight weeks after chemo and radiation therapy had best survival rates
For patients with rectal cancer

ASCO: New Regimen Effective for Locally Advanced Rectal Cancer

0
Similar effectiveness but less toxicity for short-course radiation followed by chemotherapy
Dietary glutamic acid intake is associated with reduced risk of developing colorectal cancer

Dietary Glutamic Acid Linked to Lower Risk of Colorectal Cancer

0
Significant reduction in risk for participants with body mass index of ≤25 kg/m²
A citywide colon cancer control coalition can increase colorectal cancer screening and address health disparities

Citywide Colon Cancer Control Coalition Ups Screening in NYC

0
Efforts of coalition increased screening colonoscopy from 42 percent in 2003 to almost 70 percent in 2014
Colorectal neoplasm is associated with smoking in a dose-response manner

Dose-Response Pattern for Smoking, Colorectal Neoplasm

0
Increase in non-advanced, advanced CRN with increasing smoking; no link for alcohol intake
For patients enrolled in metastatic colorectal cancer trials

Low BMI Linked to Increased Risk of Progression, Death in mCRC

0
Risk of progression and/or death highest for low BMI, decreases as BMI increases, then plateaus
Continuing a centralized mailed fecal occult blood test program is beneficial for improving adherence to colorectal cancer screening

Continuing Mailed FOBT Program Ups CRC Screening Adherence

0
Continuing benefits for patients who completed FOBT tests in years one and/or two of the program
Processed meats

WHO: Evidence That Processed Meat Can Cause Cancer

0
Meanwhile, red meat only shows some association with an increased risk for colorectal cancer
For patients with colorectal cancer

SNORA42 Identified as Novel Oncogene in Colorectal Cancer

0
Increased SNORA42 expression is independent prognostic factor for overall, disease-free survival
For patients with metastatic colorectal cancer

Extended RAS Testing Urged Before EGFR MoAB Therapy

0
Extended testing recommended for mutations in KRAS, NRAS in patients with metastatic CRC